79 related articles for article (PubMed ID: 19248780)
1. The Apc 1322T mouse develops severe polyposis associated with submaximal nuclear beta-catenin expression.
Pollard P; Deheragoda M; Segditsas S; Lewis A; Rowan A; Howarth K; Willis L; Nye E; McCart A; Mandir N; Silver A; Goodlad R; Stamp G; Cockman M; East P; Spencer-Dene B; Poulsom R; Wright N; Tomlinson I
Gastroenterology; 2009 Jun; 136(7):2204-2213.e1-13. PubMed ID: 19248780
[TBL] [Abstract][Full Text] [Related]
2. Complete deletion of Apc results in severe polyposis in mice.
Cheung AF; Carter AM; Kostova KK; Woodruff JF; Crowley D; Bronson RT; Haigis KM; Jacks T
Oncogene; 2010 Mar; 29(12):1857-64. PubMed ID: 20010873
[TBL] [Abstract][Full Text] [Related]
3. Acute WNT signalling activation perturbs differentiation within the adult stomach and rapidly leads to tumour formation.
Radulescu S; Ridgway RA; Cordero J; Athineos D; Salgueiro P; Poulsom R; Neumann J; Jung A; Patel S; Woodgett J; Barker N; Pritchard DM; Oien K; Sansom OJ
Oncogene; 2013 Apr; 32(16):2048-57. PubMed ID: 22665058
[TBL] [Abstract][Full Text] [Related]
4. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth.
Grivennikov SI; Wang K; Mucida D; Stewart CA; Schnabl B; Jauch D; Taniguchi K; Yu GY; Osterreicher CH; Hung KE; Datz C; Feng Y; Fearon ER; Oukka M; Tessarollo L; Coppola V; Yarovinsky F; Cheroutre H; Eckmann L; Trinchieri G; Karin M
Nature; 2012 Nov; 491(7423):254-8. PubMed ID: 23034650
[TBL] [Abstract][Full Text] [Related]
5. Insertional mutagenesis identifies multiple networks of cooperating genes driving intestinal tumorigenesis.
March HN; Rust AG; Wright NA; ten Hoeve J; de Ridder J; Eldridge M; van der Weyden L; Berns A; Gadiot J; Uren A; Kemp R; Arends MJ; Wessels LF; Winton DJ; Adams DJ
Nat Genet; 2011 Nov; 43(12):1202-9. PubMed ID: 22057237
[TBL] [Abstract][Full Text] [Related]
6. Newly synthesized curcumin analog has improved potential to prevent colorectal carcinogenesis in vivo.
Shibata H; Yamakoshi H; Sato A; Ohori H; Kakudo Y; Kudo C; Takahashi Y; Watanabe M; Takano H; Ishioka C; Noda T; Iwabuchi Y
Cancer Sci; 2009 May; 100(5):956-60. PubMed ID: 19445025
[TBL] [Abstract][Full Text] [Related]
7. How many mutations does it take to make a tumor?
Boland CR; Ricciardiello L
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14675-7. PubMed ID: 10611270
[No Abstract] [Full Text] [Related]
8. Beyond genetics: driving cancer with the tumour microenvironment behind the wheel.
Yuan S; Almagro J; Fuchs E
Nat Rev Cancer; 2024 Apr; 24(4):274-286. PubMed ID: 38347101
[TBL] [Abstract][Full Text] [Related]
9. Mouse models in colon cancer, inferences, and implications.
Kucherlapati MH
iScience; 2023 Jun; 26(6):106958. PubMed ID: 37332609
[TBL] [Abstract][Full Text] [Related]
10. The Role of WNT Pathway Mutations in Cancer Development and an Overview of Therapeutic Options.
Groenewald W; Lund AH; Gay DM
Cells; 2023 Mar; 12(7):. PubMed ID: 37048063
[TBL] [Abstract][Full Text] [Related]
11. An innate IL-25-ILC2-MDSC axis creates a cancer-permissive microenvironment for
Jou E; Rodriguez-Rodriguez N; Ferreira AF; Jolin HE; Clark PA; Sawmynaden K; Ko M; Murphy JE; Mannion J; Ward C; Matthews DJ; Buczacki SJA; McKenzie ANJ
Sci Immunol; 2022 Jun; 7(72):eabn0175. PubMed ID: 35658010
[TBL] [Abstract][Full Text] [Related]
12. NOTUM from Apc-mutant cells biases clonal competition to initiate cancer.
Flanagan DJ; Pentinmikko N; Luopajärvi K; Willis NJ; Gilroy K; Raven AP; Mcgarry L; Englund JI; Webb AT; Scharaw S; Nasreddin N; Hodder MC; Ridgway RA; Minnee E; Sphyris N; Gilchrist E; Najumudeen AK; Romagnolo B; Perret C; Williams AC; Clevers H; Nummela P; Lähde M; Alitalo K; Hietakangas V; Hedley A; Clark W; Nixon C; Kirschner K; Jones EY; Ristimäki A; Leedham SJ; Fish PV; Vincent JP; Katajisto P; Sansom OJ
Nature; 2021 Jun; 594(7863):430-435. PubMed ID: 34079124
[TBL] [Abstract][Full Text] [Related]
13. Not All Wnt Activation Is Equal: Ligand-Dependent versus Ligand-Independent Wnt Activation in Colorectal Cancer.
Kleeman SO; Leedham SJ
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33202731
[TBL] [Abstract][Full Text] [Related]
14. Mutations and mechanisms of WNT pathway tumour suppressors in cancer.
Bugter JM; Fenderico N; Maurice MM
Nat Rev Cancer; 2021 Jan; 21(1):5-21. PubMed ID: 33097916
[TBL] [Abstract][Full Text] [Related]
15. Human Colorectal Cancer from the Perspective of Mouse Models.
Stastna M; Janeckova L; Hrckulak D; Kriz V; Korinek V
Genes (Basel); 2019 Oct; 10(10):. PubMed ID: 31614493
[TBL] [Abstract][Full Text] [Related]
16. Loss of BCL9/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer.
Gay DM; Ridgway RA; Müller M; Hodder MC; Hedley A; Clark W; Leach JD; Jackstadt R; Nixon C; Huels DJ; Campbell AD; Bird TG; Sansom OJ
Nat Commun; 2019 Feb; 10(1):723. PubMed ID: 30760720
[TBL] [Abstract][Full Text] [Related]
17. Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in FAP mouse models.
Mieszczanek J; van Tienen LM; Ibrahim AEK; Winton DJ; Bienz M
Nat Commun; 2019 Feb; 10(1):724. PubMed ID: 30760710
[TBL] [Abstract][Full Text] [Related]
18. Validation and application of a novel APC antibody in western blotting, immunoprecipitation, and immunohistochemistry.
Yamada NO; Wenduerma ; Matsuda S; Senda T
Med Mol Morphol; 2018 Dec; 51(4):227-236. PubMed ID: 29923125
[TBL] [Abstract][Full Text] [Related]
19. Itraconazole targets cell cycle heterogeneity in colorectal cancer.
Buczacki SJA; Popova S; Biggs E; Koukorava C; Buzzelli J; Vermeulen L; Hazelwood L; Francies H; Garnett MJ; Winton DJ
J Exp Med; 2018 Jul; 215(7):1891-1912. PubMed ID: 29853607
[TBL] [Abstract][Full Text] [Related]
20. Paracrine cyclooxygenase-2 activity by macrophages drives colorectal adenoma progression in the Apc
Hull MA; Cuthbert RJ; Ko CWS; Scott DJ; Cartwright EJ; Hawcroft G; Perry SL; Ingram N; Carr IM; Markham AF; Bonifer C; Coletta PL
Sci Rep; 2017 Jul; 7(1):6074. PubMed ID: 28729694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
